Oxford BioMedica PLC Cash Flow-to-Debt Ratio
Oxford BioMedica PLC cash flow-to-debt ratio. Oxford BioMedica PLC (OXB) has a Cash Flow-to-Debt Ratio of 0.01x as of June 2025, meaning its operating cash flow of GBX2.35 Million could theoretically repay 0% of its total liabilities (GBX183.59 Million) in one year. Check how aggressively does Oxford BioMedica PLC reinvest cash to assess the company's total reinvestment commitment from operating cash flow.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of Oxford BioMedica PLC (1996–2024)
Cash flow-to-debt ratio of Oxford BioMedica PLC from 1996 to 2024. Historical debt coverage capacity for Oxford BioMedica PLC across 28 annual periods. Check Oxford BioMedica PLC (OXB) cash earnings ratio to evaluate the quality of earnings relative to operating cash generation.
Oxford BioMedica PLC Cash Flow-to-Debt Ratio by Year (1996–2024)
Oxford BioMedica PLC cash flow-to-debt ratio by year from 1996 to 2024. Year-by-year debt coverage analysis for Oxford BioMedica PLC. For the full cash flow conversion analysis, see OXB cash generation efficiency.
| Year | CF-to-Debt Ratio | Operating CF (GBX) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | -0.30x | GBX-50.63 Million | GBX171.16 Million | ▼ -81.0% |
| 2023 | -0.16x | GBX-28.52 Million | GBX174.51 Million | ▼ -190.2% |
| 2022 | -0.06x | GBX-12.62 Million | GBX223.99 Million | ▼ -111.0% |
| 2021 | 0.51x | GBX25.45 Million | GBX49.89 Million | ▲ +1065.5% |
| 2020 | 0.04x | GBX3.12 Million | GBX71.18 Million | ▲ +159.0% |
| 2019 | -0.07x | GBX-3.51 Million | GBX47.30 Million | ▼ -144.8% |
| 2018 | 0.17x | GBX12.87 Million | GBX77.66 Million | ▲ +229.6% |
| 2017 | 0.05x | GBX2.98 Million | GBX59.26 Million | ▲ +143.6% |
| 2016 | -0.12x | GBX-5.11 Million | GBX44.33 Million | ▲ +64.0% |
| 2015 | -0.32x | GBX-13.12 Million | GBX40.96 Million | ▲ +42.8% |
| 2014 | -0.56x | GBX-6.03 Million | GBX10.77 Million | ▲ +75.9% |
| 2013 | -2.32x | GBX-11.02 Million | GBX4.75 Million | ▼ -10.6% |
| 2012 | -2.10x | GBX-10.04 Million | GBX4.78 Million | ▼ -34.6% |
| 2011 | -1.56x | GBX-12.98 Million | GBX8.32 Million | ▼ -70.7% |
| 2010 | -0.91x | GBX-12.83 Million | GBX14.04 Million | ▼ -1007.1% |
| 2009 | 0.10x | GBX2.31 Million | GBX22.97 Million | ▲ +111.0% |
| 2008 | -0.91x | GBX-18.13 Million | GBX19.85 Million | ▼ -664.5% |
| 2007 | 0.16x | GBX4.73 Million | GBX29.23 Million | ▲ +105.1% |
| 2006 | -3.14x | GBX-17.13 Million | GBX5.45 Million | ▲ +0.5% |
| 2005 | -3.16x | GBX-8.34 Million | GBX2.64 Million | ▲ +32.8% |
| 2004 | -4.70x | GBX-10.37 Million | GBX2.21 Million | ▲ +26.4% |
| 2003 | -6.38x | GBX-9.58 Million | GBX1.50 Million | ▲ +21.9% |
| 2002 | -8.17x | GBX-10.30 Million | GBX1.26 Million | ▼ -64.4% |
| 2001 | -4.97x | GBX-8.73 Million | GBX1.76 Million | ▼ -36.0% |
| 2000 | -3.66x | GBX-4.90 Million | GBX1.34 Million | ▲ +18.2% |
| 1999 | -4.47x | GBX-3.58 Million | GBX801.00K | ▲ +36.3% |
| 1998 | -7.03x | GBX-3.37 Million | GBX480.00K | ▼ -3588.1% |
| 1996 | -0.19x | GBX-24.00K | GBX126.00K | — |